{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T13:22:39Z","timestamp":1789910559737,"version":"4.0.1"},"reference-count":4,"publisher":"American Diabetes Association","issue":"3","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,3,1]]},"DOI":"10.2337\/diacare.28.3.754","type":"journal-article","created":{"date-parts":[[2007,3,5]],"date-time":"2007-03-05T22:51:27Z","timestamp":1173135087000},"page":"754-755","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":33,"title":["Adipocytokines as a Novel Target for the Anti-inflammatory Effect of Atorvastatin in Patients With Type 2 Diabetes"],"prefix":"10.2337","volume":"28","author":[{"given":"Maximilian","family":"von Eynatten","sequence":"first","affiliation":[{"name":"From the Department of Endocrinology and Metabolism, Ruprecht-Karls-University of Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen G.","family":"Schneider","sequence":"additional","affiliation":[{"name":"From the Department of Endocrinology and Metabolism, Ruprecht-Karls-University of Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senad","family":"Hadziselimovic","sequence":"additional","affiliation":[{"name":"From the Department of Endocrinology and Metabolism, Ruprecht-Karls-University of Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Hamann","sequence":"additional","affiliation":[{"name":"From the Department of Endocrinology and Metabolism, Ruprecht-Karls-University of Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"Bierhaus","sequence":"additional","affiliation":[{"name":"From the Department of Endocrinology and Metabolism, Ruprecht-Karls-University of Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter P.","family":"Nawroth","sequence":"additional","affiliation":[{"name":"From the Department of Endocrinology and Metabolism, Ruprecht-Karls-University of Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus A.","family":"Dugi","sequence":"additional","affiliation":[{"name":"From the Department of Endocrinology and Metabolism, Ruprecht-Karls-University of Heidelberg, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","reference":[{"key":"2022031218453388400_R1","doi-asserted-by":"crossref","unstructured":"Shetty GK, Economides PA, Horton ES, Mantzoros CS, Veves A: Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes. Diabetes Care\u200827:2450\u20132457, 2004","DOI":"10.2337\/diacare.27.10.2450"},{"key":"2022031218453388400_R2","doi-asserted-by":"crossref","unstructured":"Shamsuzzaman ASM, Winnicki M, Wolk R, Svatikova A, Phillips BG, Davison DE, Berger PB, Somers VK: Independent association between plasma leptin and C-reactive protein in healthy humans. Circulation\u2008109:2181\u20132185, 2004","DOI":"10.1161\/01.CIR.0000127960.28627.75"},{"key":"2022031218453388400_R3","doi-asserted-by":"crossref","unstructured":"Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, Thomason MJ, Mackness MI, Charlton-Menys V, Fuller JH, CARDS investigators: Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet\u2008364:685\u2013696, 2004","DOI":"10.1016\/S0140-6736(04)16895-5"},{"key":"2022031218453388400_R4","doi-asserted-by":"crossref","unstructured":"McTernan PG, Fisher FM, Valsamakis G, Chetty R, Harte A, McTernan CL, Clark PM, Smith SA, Barnett AH, Kumar S: Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipoycytes. J Clin Endocrinol Metab\u200888:6098\u20136106, 2003","DOI":"10.1210\/jc.2003-030898"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/28\/3\/754\/654735\/754.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/28\/3\/754\/654735\/754.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T19:50:24Z","timestamp":1647114624000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/28\/3\/754\/27776\/Adipocytokines-as-a-Novel-Target-for-the-Anti"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3,1]]},"references-count":4,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,3,1]]}},"URL":"https:\/\/doi.org\/10.2337\/diacare.28.3.754","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3,1]]}}}